Association of PPARalpha gene polymorphisms and lipid serum levels in a Brazilian elderly population (Q43676995)

25 November 2017

Association of PPARalpha gene polymorphisms and lipid serum levels in a Brazilian elderly population (English)

1 reference

25 November 2017

Elizabeth Suchi Chen

1

0 references

author name string

Diego Robles Mazzotti

2

1 reference

25 November 2017

Tatiane Katsue Furuya

3

1 reference

25 November 2017

Maysa Seabra Cendoroglo

4

1 reference

25 November 2017

Luiz Roberto Ramos

5

1 reference

25 November 2017

Lara Quirino Araujo

6

1 reference

25 November 2017

Rommel Rodriguez Burbano

7

1 reference

25 November 2017

Marília de Arruda Cardoso Smith

8

1 reference

25 November 2017

12 October 2009

1 reference

Experimental and Molecular Pathology

25 November 2017

1 reference

25 November 2017

88

1 reference

25 November 2017

197-201

1 reference

25 November 2017

1

1 reference

Synergistic effect between polymorphisms of PPARA and ABCA1 genes on the premature coronary artery disease

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Applicability of the CERAD neuropsychological battery to Brazilian elderly.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Validity of a Brazilian Version of the Older Americans Resources and Services (OARS) Mental Health Screening Questionnaire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Polymorphism in the peroxisome proliferator-activated receptor alpha gene influences the risk for Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

APO A-V-1131T-->C polymorphism frequency and its association with morbidity in a Brazilian elderly population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Evidence that triglycerides are an independent coronary heart disease risk factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

LDA—a java-based linkage disequilibrium analyzer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Association of common variation in the PPARA gene with incident myocardial infarction in individuals with type 2 diabetes: a Go-DARTS study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

A polymorphism, L162V, in the peroxisome proliferator-activated receptor alpha (PPARalpha) gene is associated with lower body mass index in patients with non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Variation in the PPARα gene is associated with altered function in vitro and plasma lipid concentrations in Type II diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Peroxisome proliferator-activated receptor alpha gene variation influences age of onset and progression of type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Response to micronized fenofibrate treatment is associated with the peroxisome-proliferator-activated receptors alpha G/C intron7 polymorphism in subjects with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Mechanism of triglyceride lowering in mice expressing human apolipoprotein A5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Population prevalence of APOE, APOC3 and PPAR-? mutations associated to hypertriglyceridemia in French Canadians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Peroxisome proliferator-activated receptor-alpha (PPARA) genetic polymorphisms and breast cancer risk: a Long Island ancillary study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Peroxisome proliferator--activated receptor alpha gene regulates left ventricular growth in response to exercise and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Trends in death from circulatory diseases in Brazil between 1979 and 1996

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Peroxisome proliferator-activated receptor alpha activates cyclooxygenase-2 gene transcription through bile acid transport in human colorectal cancer cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

The Human Apolipoprotein AV Gene Is Regulated by Peroxisome Proliferator-activated Receptor-α and Contains a Novel Farnesoid X-activated Receptor Response Element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Two-year follow-up study of elderly residents in S. Paulo, Brazil: methodology and preliminary results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Association between the PPARalpha-L162V polymorphism and components of the metabolic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

The human peroxisome proliferator-activated receptor alpha gene: identification and functional characterization of two natural allelic variants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

The PPAR-alpha gene in Alzheimer's disease: lack of replication of earlier association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

The dependence of serum interleukin-6 level on PPAR-alpha polymorphism in men with coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Relationships between the functional PPARalpha Leu162Val polymorphism and obesity, type 2 diabetes, dyslipidaemia, and related quantitative traits in studies of 5799 middle-aged white people.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Association between the PPARA L162V polymorphism and plasma lipid levels: the Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Peroxisome proliferator-activated receptor alpha polymorphisms and postprandial lipemia in healthy men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Is fasting glucose sufficient to define diabetes? Epidemiological data from 20 European studies. The DECODE-study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic Criteria in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Peroxisome proliferator-activated receptor [alpha] genetic variation interacts with n-6 and long-chain n-3 fatty acid intake to affect total cholesterol and LDL-cholesterol concentrations in the Atherosclerosis Risk in Communities Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

Single gene contributions: genetic variants of peroxisome proliferator-activated receptor (isoforms alpha, beta/delta and gamma) and mechanisms of dyslipidemias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2009.10.001

10.1016/J.YEXMP.2009.10.001

7 January 2021

Identifiers

DOI

1 reference

25 November 2017

1 reference